Title
Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia
A Prospective, Randomized, Open-label Multicenter Study Comparing the Pharmaceutical Economics and Effectiveness of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia in Laparoscopic Surgeries in China
Phase
Phase 4Lead Sponsor
AbbottStudy Type
InterventionalStatus
Completed Results PostedIndication/Condition
Elective Laparoscopic SurgeryIntervention/Treatment
propofol sevoflurane ...Study Participants
336This study is being performed to compare the cost of anesthetic techniques with sevoflurane (low fresh gas flow balanced anesthesia) versus propofol (target controlled infusion [TCI]) versus propofol induction and sevoflurane maintenance anesthesia in subjects undergoing elective laparoscopic surgery with predicted anesthesic use between 1 and 3 hour duration.
Three hundred thirty-six subjects were enrolled in this study. Two subjects, one treated with propofol for induction and maintenance and one treated with propofol for induction and sevoflurane for maintenance are not included in the study participation since no information was available for these two subjects.
Sevoflurane was administered at a concentration of 8% via vital capacity induction and sevoflurane 0.8-1.5 minimum alveolar concentration (MAC) with a rate of 1 L/min fresh gas flow for maintenance.
Propofol IV 4 ug/mL was administered with target controlled infusion (TCI) for induction and propofol 3 to 6 ug/mL was administered with TCI for maintenance.
Propofol was administered as a bolus IV dose of 1.5 mg/kg for induction at a rate of 40 mg/10 seconds. During maintenance, a sevoflurane concentration of 0.8-1.5 minimal alveolar concentration (MAC) was administered at a rate of 1 L/min fresh gas flow.
Subjects received sevoflurane, a inhalational (volatile) anesthetic, which was administered for induction and maintenance of general anesthesia. Inhalational induction was induced via vital capacity induction at 8% and maintained at 0.8-1.5 minimum alveolar concentration (MAC).
Subjects received propofol, an intravenous (IV) anesthetic, which was administered for induction and maintenance of general anesthesia.
Subjects received a bolus dose of propofol of 1.5 mg/kg administered for IV induction followed by sevoflurane at 0.8-1.5 MAC for maintenance anesthesia.
Inclusion Criteria Men or women, aged from 18 to 65 ASA (American Society of Anesthesiologists) physical status (a requirement of the subject's physical status): I or II Body mass index (weight/height^2) from 16 to 30 kg/m^2 Elective laparoscopic surgery requiring general anesthesia managed with endotracheal intubation Duration of anesthesia use will be greater than or equal to 1 hour, but less than 3 hours in length. Exclusion Criteria Hypersensitivity or unusual response to any halogenated anesthetics. History of significant cardiovascular, pulmonary, hepatic, renal, central nervous system or muscular disease. Pre-operative cognitive dysfunction or disabling neuropsychiatric disorders. Need for emergency surgery or surgery requiring additional regional anesthetic techniques. Need for intracranial surgery, cardio-surgery or thoracic surgery. Subjects inability to cooperate with the anesthetist before administration of the anesthetic agent. Personal or familial history of malignant hyperthermia. Females who are either pregnant or breast feeding.
| Event Type | Organ System | Event Term | Sevoflurane | Propofol | Propofol Induction Sevoflurane Maintenance |
|---|
[Cost of VIMA = unit price of sevoflurane X used volume of sevoflurane]; [Cost of TIVA = unit price of propofol X total volume of propofol in the syringe]; [Cost of Propofol Induction and Sevoflurane Maintenance = unit price of propofol X total volume of propofol in the syringe + unit price of sevoflurane X volume of sevoflurane in the syringe]. The total volume of propofol in the syringe was calculated, even if all the anesthetic was not used, because it could not be reused.
Loss of consciousness was measured from the time the anesthetic was administered until loss of consciousness (no response to command) occurred. Inhalational induction was induced with sevoflurane via vital capacity induction at 8%. Intravenous induction was induced with propofol at 4 µg/mL via target controlled infusion (TCI). In subjects who received both anesthetic agents, a bolus dose of propofol 1.5 mg/kg was used for induction.
Measured from the time sevoflurane or propofol administration was stopped until the subject's eyes were opened. The investigator tapped the subject on the forehead or shoulder after anesthesia was stopped and asked them to open their eyes. This process was repeated approximately every minute until eye opening occurred.
Time to extubation was measured from the time sevoflurane or propofol administration was stopped until tracheal extubation occurred. Criteria to determine extubation included a train of four stimulus > 0.9 (a method to measure the magnitude and type of neuromuscular block, a ratio of the fourth response to the first one), a tidal volume > 5 mL/kg, minute ventilation > 3 L, a respiratory rate of > 10 breaths/minute, an end tidal carbon dioxide < 45 mmHg, and eye opening has occurred.
Time to orientation was measured from the time sevoflurane or propofol administration was stopped until orientation (able to state their name and date of birth).
